Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab.
Schultheis AM, Lurje G, Rhodes KE, Zhang W, Yang D, Garcia AA, Morgan R, Gandara D, Scudder S, Oza A, Hirte H, Fleming G, Roman L, Lenz HJ.
Schultheis AM, et al. Among authors: oza a.
Clin Cancer Res. 2008 Nov 15;14(22):7554-63. doi: 10.1158/1078-0432.CCR-08-0351.
Clin Cancer Res. 2008.
PMID: 19010874
Free PMC article.
Clinical Trial.